Kristie Grebe

Company: Anokion Inc.

Job title: Chief Scientific Officer

Seminars:

Informing Late-Stage Biomarker Strategies: Learnings from Early In-Human Studies to Inform Future Trial Design 1:45 pm

Going from cell-based assays into symptoms or disease markers for tolerance studies Delving into preclinical and clinical development for antigen specific autoimmune diseaseRead more

day: Conference Day One

Panel & Audience Discussion: Supercharging Antigen-Specific Approaches to Autoimmune Disease Patients: Evaluating the Next Steps to Move Forward as a Field 3:45 pm

Selecting antigens – what makes a ‘good’ antigen? Assessing preclinical models – what should we move towards for regulatory buy-in? Creating a biomarker toolbox – what biomarkers could be a tolerance endpoint? Honing clinical study design – what are key considerations for tolerance?Read more

day: Conference Day Two